Literature DB >> 16054505

Novel oral drug administration in an animal model of neuroleptic therapy.

Sonja B Schleimer1, Graham A R Johnston, Jasmine M Henderson.   

Abstract

A novel method of oral drug administration was used in a neuroleptic animal study. Seventy male Sprague-Dawley rats were randomly subdivided into four groups, which were treated with clozapine, haloperidol, diazepam or a vehicle solution (5% sucrose solution). Oral drug treatment was achieved by training the rats to drink the drug of choice mixed with five percent sucrose or vehicle solution from a syringe. Within 3-4 weeks the haloperidol group developed vacuous chewing movement, which did not disappear with discontinuation of the drug. Significant weight gain was observed for all drug groups in relation to the control group, whereas only the diazepam group showed a significant increase in response latency on the disengage test of sensorimotor function, which disappeared with drug withdrawal. A novel means of testing the motivational status showed that all drug-treated groups engaged in eating chocolate before grooming (t=11.69, p<0.001), whereas the control group showed no specific tendency towards either task. Furthermore, there was a significant delay in grooming for the haloperidol group compared to the other drug groups and controls. In conclusion, a novel method of oral drug administration with minimum stress was introduced that was sufficient to cause the described changes in behavioural parameters. Additionally, the combination of tests used provided an efficient discrimination between the behavioural effects of clozapine, haloperidol and diazepam in rodents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054505     DOI: 10.1016/j.jneumeth.2005.02.004

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  11 in total

1.  Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.

Authors:  Tanuja Bordia; J Michael McIntosh; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2011-12-05       Impact factor: 4.030

2.  Alternative method of oral dosing for rats.

Authors:  Zeenat Atcha; Claire Rourke; Aveline Hp Neo; Catherine Wh Goh; Jean Sk Lim; Chiu-Cheong Aw; Edward R Browne; Darrel J Pemberton
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-05       Impact factor: 1.232

3.  Voluntary ingestion of antiparasitic drugs emulsified in honey represents an alternative to gavage in mice.

Authors:  Tatiana Küster; Beatrice Zumkehr; Corina Hermann; Regula Theurillat; Wolfgang Thormann; Bruno Gottstein; Andrew Hemphill
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

4.  Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays.

Authors:  Emma Perez-Costas; Paolo Guidetti; Miguel Melendez-Ferro; Joyce J Kelley; Rosalinda C Roberts
Journal:  J Neural Transm (Vienna)       Date:  2008-01-11       Impact factor: 3.575

5.  A novel method for oral delivery of drug compounds to the neonatal SMNDelta7 mouse model of spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Jonathan D Edwards; Kristie R Schussler; Arthur H M Burghes
Journal:  J Neurosci Methods       Date:  2006-12-11       Impact factor: 2.390

6.  Voluntary oral dosing for precise experimental compound delivery in adult rats.

Authors:  Kyle C Chesler; Cara T Motz; Katie L Bales; Rachael A Allen; Harrison K Vo; Machelle T Pardue
Journal:  Lab Anim       Date:  2021-08-14       Impact factor: 2.908

7.  Comparison of Gelatin Flavors for Oral Dosing of C57BL/6J and FVB/N Mice.

Authors:  Tânia Martins; Ana F Matos; Joana Soares; Rúben Leite; Maria J Pires; Tiago Ferreira; Beatriz Medeiros-Fonseca; Eduardo Rosa; Paula A Oliveira; Luís M Antunes
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-11-30       Impact factor: 1.706

8.  Laboratory environment and bio-medical experience: the impact of administration technique on the quality of immune-behavior data results in stress experience.

Authors:  Nessaibia Issam; Tahraoui Abdelkrim; Chouba Ibtissem; Kaarar Narjess
Journal:  Bioimpacts       Date:  2015-12-28

9.  Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies.

Authors:  Fabio Panariello; Vincenzo De Luca; Andrea de Bartolomeis
Journal:  Schizophr Res Treatment       Date:  2010-12-06

10.  Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats.

Authors:  Jana Lotter; Marisa Möller; Olivia Dean; Michael Berk; Brian H Harvey
Journal:  Front Psychiatry       Date:  2020-03-31       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.